UBS Raises PHINIA Price Target to $69 From $68, Keeps Neutral Rating
UBS increased its PHINIA price target from $68 to $69 and maintained a neutral rating. The adjustment follows the company’s third-quarter 2026 earnings report and updated guidance on October 29, 2026.